カイオム・バイオサイエンスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2014/08/11 | 1,317 | 1,393 | 1,295 | 1,362 | +80 | +6.2% | 339,100 |
| 2014/08/08 | 1,302 | 1,310 | 1,243 | 1,282 | -44 | -3.3% | 286,500 |
| 2014/08/07 | 1,316 | 1,347 | 1,293 | 1,326 | -3 | -0.2% | 212,900 |
| 2014/08/06 | 1,357 | 1,380 | 1,315 | 1,329 | -48 | -3.5% | 336,800 |
| 2014/08/05 | 1,415 | 1,433 | 1,377 | 1,377 | -47 | -3.3% | 225,200 |
| 2014/08/04 | 1,400 | 1,437 | 1,366 | 1,424 | +29 | +2.1% | 200,900 |
| 2014/08/01 | 1,401 | 1,412 | 1,371 | 1,395 | -47 | -3.3% | 331,900 |
| 2014/07/31 | 1,440 | 1,450 | 1,404 | 1,442 | -16 | -1.1% | 345,000 |
| 2014/07/30 | 1,485 | 1,489 | 1,456 | 1,458 | -19 | -1.3% | 160,300 |
| 2014/07/29 | 1,466 | 1,496 | 1,438 | 1,477 | -2 | -0.1% | 285,000 |
| 2014/07/28 | 1,500 | 1,526 | 1,468 | 1,479 | +1 | +0.1% | 186,100 |
| 2014/07/25 | 1,441 | 1,483 | 1,430 | 1,478 | +23 | +1.6% | 230,000 |
| 2014/07/24 | 1,458 | 1,525 | 1,421 | 1,455 | -30 | -2% | 531,400 |
| 2014/07/23 | 1,404 | 1,525 | 1,403 | 1,485 | +94 | +6.8% | 496,800 |
| 2014/07/22 | 1,400 | 1,407 | 1,371 | 1,391 | -12 | -0.9% | 243,900 |
| 2014/07/18 | 1,340 | 1,429 | 1,327 | 1,403 | +11 | +0.8% | 382,000 |
| 2014/07/17 | 1,458 | 1,470 | 1,390 | 1,392 | -74 | -5% | 440,900 |
| 2014/07/16 | 1,524 | 1,545 | 1,457 | 1,466 | -28 | -1.9% | 295,500 |
| 2014/07/15 | 1,470 | 1,519 | 1,465 | 1,494 | +24 | +1.6% | 311,000 |
| 2014/07/14 | 1,480 | 1,500 | 1,455 | 1,470 | -12 | -0.8% | 269,900 |
| 2014/07/11 | 1,451 | 1,527 | 1,435 | 1,482 | -23 | -1.5% | 597,000 |
| 2014/07/10 | 1,612 | 1,696 | 1,501 | 1,505 | +13 | +0.9% | 3,582,700 |
| 2014/07/09 | 1,500 | 1,520 | 1,481 | 1,492 | -54 | -3.5% | 406,700 |
| 2014/07/08 | 1,562 | 1,574 | 1,536 | 1,546 | -49 | -3.1% | 338,800 |
| 2014/07/07 | 1,606 | 1,619 | 1,580 | 1,595 | -34 | -2.1% | 263,300 |
| 2014/07/04 | 1,600 | 1,630 | 1,553 | 1,629 | +78 | +5% | 434,500 |
| 2014/07/03 | 1,594 | 1,605 | 1,530 | 1,551 | -54 | -3.4% | 564,600 |
| 2014/07/02 | 1,625 | 1,639 | 1,585 | 1,605 | -18 | -1.1% | 411,000 |
| 2014/07/01 | 1,660 | 1,680 | 1,601 | 1,623 | -3 | -0.2% | 349,100 |
| 2014/06/30 | 1,594 | 1,670 | 1,592 | 1,626 | -7 | -0.4% | 527,300 |
| 2014/06/27 | 1,688 | 1,699 | 1,579 | 1,633 | -102 | -5.9% | 761,800 |
| 2014/06/26 | 1,785 | 1,798 | 1,701 | 1,735 | -45 | -2.5% | 466,000 |
| 2014/06/25 | 1,865 | 1,884 | 1,772 | 1,780 | -105 | -5.6% | 720,200 |
| 2014/06/24 | 1,860 | 1,912 | 1,831 | 1,885 | +45 | +2.4% | 884,900 |
| 2014/06/23 | 1,769 | 1,855 | 1,759 | 1,840 | +82 | +4.7% | 627,000 |
| 2014/06/20 | 1,869 | 1,884 | 1,718 | 1,758 | -92 | -5% | 1,106,100 |
| 2014/06/19 | 1,890 | 1,928 | 1,829 | 1,850 | -46 | -2.4% | 789,000 |
| 2014/06/18 | 1,910 | 1,975 | 1,855 | 1,896 | -30 | -1.6% | 981,500 |
| 2014/06/17 | 1,893 | 1,964 | 1,854 | 1,926 | +22 | +1.2% | 1,510,200 |
| 2014/06/16 | 1,850 | 2,015 | 1,835 | 1,904 | +72 | +3.9% | 2,533,500 |
| 2014/06/13 | 1,720 | 1,840 | 1,715 | 1,832 | +104 | +6% | 1,580,700 |
| 2014/06/12 | 1,720 | 1,798 | 1,713 | 1,728 | -32 | -1.8% | 869,400 |
| 2014/06/11 | 1,656 | 1,784 | 1,642 | 1,760 | +51 | +3% | 1,037,600 |
| 2014/06/10 | 1,779 | 1,847 | 1,706 | 1,709 | +1 | +0.1% | 2,984,100 |
| 2014/06/09 | 1,600 | 1,735 | 1,582 | 1,708 | +126 | +8% | 1,415,700 |
| 2014/06/06 | 1,565 | 1,593 | 1,532 | 1,582 | +18 | +1.2% | 450,700 |
| 2014/06/05 | 1,673 | 1,675 | 1,526 | 1,564 | -78 | -4.8% | 720,800 |
| 2014/06/04 | 1,663 | 1,685 | 1,614 | 1,642 | -18 | -1.1% | 810,400 |
| 2014/06/03 | 1,660 | 1,735 | 1,612 | 1,660 | +35 | +2.2% | 1,250,800 |
| 2014/06/02 | 1,635 | 1,670 | 1,586 | 1,625 | +25 | +1.6% | 1,062,500 |
2501～
2550
件表示中 / 3150件
類似銘柄と比較する
現在ご覧いただいている「カイオム」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カイオム | 9,900円 | +2.6% | - | 0.00% | - | 5.73倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
| ノイルイミューン | 16,500円 | -5.1% | - | 0.00% | - | 1.43倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| 日ケミファ | 150,100円 | +2.5% | - | 3.33% | 90.26倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ＶＩＳ | 91,000円 | +87.8% | +265.7% | 0.00% | 54.65倍 | 2.51倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
| カルナバイオ | 30,400円 | -43.1% | - | 0.00% | - | 1.81倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
市場注目の銘柄
チャート関連のコラム
